News

A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...
Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...
Although AbbVie, Eli Lilly ... tariff impact. Michaels noted "penalties in the government channel and with existing contracts in the commercial setting" as barriers to hiking drug prices.
Trump’s drug pricing order sparks global pharma sell-off as industry warns of stifled innovation and revenue loss in key US ...
Trump's order looking to cut prescription drug prices is bearish for drug stocks at the surface, but is the worst already priced in?